Koyfin Home > Directory > Health Care > Horizon Therapeutics > Gross Profit

Horizon Therapeutics Gross Profit Chart (HZNP)

Horizon Therapeutics annual/quarterly Gross Profit from 2010 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Horizon Therapeutics Gross Profit for the quarter ending September 09, 2020 was $485m a 44.61% increase of 216m year over year
  • Horizon Therapeutics Gross Profit for the last 12 months ending September 09, 2020 was $1,353m a 30.69% increase of 415m year over year
  • Horizon Therapeutics Annual Gross Profit for 2019 was $938m a 11.13% increase of 104m from 2018
  • Horizon Therapeutics Annual Gross Profit for 2018 was $834m a 18.18% increase of 152m from 2017
  • Horizon Therapeutics Annual Gross Profit for 2017 was $682m a 3.19% increase of 22m from 2016
Other Income Statement Metrics:
  • Horizon Therapeutics EBITDA for the quarter ending December 12, 2018 was $54m a 229.73% increase of 125m year over year
  • Horizon Therapeutics Net Income for the quarter ending December 12, 2018 was $88m a 279.68% increase of 245m year over year
  • Horizon Therapeutics Total Revenue for the quarter ending December 12, 2018 was $356m a 37.03% increase of 132m year over year
View Chart On Koyfin

Quarterly HZNP Gross Profit Data

09/2020$485m
06/2020$341m
03/2020$258m
12/2019$269m
09/2019$246m
06/2019$231m
03/2019$192m
12/2018$257m
09/2018$234m
06/2018$212m

Annual HZNP Gross Profit Data

2019$938m
2018$834m
2017$682m
2016$660m
2015$549m
2014$229m
2013$59m
2012$7m
2011$0m
2010$-2m